ATE198422T1 - Erweichende zusammensetzung - Google Patents

Erweichende zusammensetzung

Info

Publication number
ATE198422T1
ATE198422T1 AT92907505T AT92907505T ATE198422T1 AT E198422 T1 ATE198422 T1 AT E198422T1 AT 92907505 T AT92907505 T AT 92907505T AT 92907505 T AT92907505 T AT 92907505T AT E198422 T1 ATE198422 T1 AT E198422T1
Authority
AT
Austria
Prior art keywords
pct
emollient
composition
sec
actinic
Prior art date
Application number
AT92907505T
Other languages
English (en)
Inventor
William Henry Lee
Original Assignee
Bioglan Ireland R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10692198&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE198422(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioglan Ireland R & D Ltd filed Critical Bioglan Ireland R & D Ltd
Application granted granted Critical
Publication of ATE198422T1 publication Critical patent/ATE198422T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT92907505T 1991-03-26 1992-03-26 Erweichende zusammensetzung ATE198422T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919106365A GB9106365D0 (en) 1991-03-26 1991-03-26 An emollient for use with ultraviolet light
PCT/GB1992/000556 WO1992017208A1 (en) 1991-03-26 1992-03-26 An emollient composition

Publications (1)

Publication Number Publication Date
ATE198422T1 true ATE198422T1 (de) 2001-01-15

Family

ID=10692198

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907505T ATE198422T1 (de) 1991-03-26 1992-03-26 Erweichende zusammensetzung

Country Status (13)

Country Link
US (1) US5501849A (de)
EP (1) EP0702568B1 (de)
JP (1) JPH06507391A (de)
KR (1) KR100243758B1 (de)
AT (1) ATE198422T1 (de)
AU (1) AU671584B2 (de)
CA (1) CA2106065A1 (de)
DE (1) DE69231628D1 (de)
GB (1) GB9106365D0 (de)
IE (1) IE920975A1 (de)
NZ (1) NZ242148A (de)
SG (1) SG49928A1 (de)
WO (1) WO1992017208A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9306473D0 (en) * 1993-03-29 1993-05-19 Bioglan Lab Ltd Pharmaceutically useful compounds
US5556612A (en) * 1994-03-15 1996-09-17 The General Hospital Corporation Methods for phototherapeutic treatment of proliferative skin diseases
US6093745A (en) * 1997-11-25 2000-07-25 Psorx, L.L.C. Methods and composition for treating skin proliferative diseases
US6174535B1 (en) 1999-06-28 2001-01-16 Larry D. Lundmark Hydrated honey gel polymeric compositions and process for preparing same
US20030215397A1 (en) * 2002-05-14 2003-11-20 Noah Patricia W. Method of treatment of skin diseases related to microbial antigens in the skin
US20140080924A1 (en) * 2012-09-17 2014-03-20 Richard T. Rigg Self-emulsifying and stabilizing gel for stabilizing cosmetic compositions
HU230989B1 (hu) 2013-01-17 2019-08-28 Gd Photonics Kft. Készítmény az UVB-fényterápia hatékonyságának fokozására, eljárás annak előállítására és alkalmazása
KR20170023776A (ko) 2014-02-26 2017-03-06 루마 세러퓨틱스 인코포레이티드 자외선 광선 치료 장치들 및 방법들
KR20180134856A (ko) 2016-02-09 2018-12-19 루마 세러퓨틱스 인코포레이티드 광선요법에 의해 건선을 치료하기 위한 방법, 조성물 및 장치

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194007A (en) * 1978-01-13 1980-03-18 Scott Eugene J Van α-Hydroxyretinoic acid, α-ketoretinoic acid and mixtures and their use in treating skin conditions
BR7904612A (pt) * 1978-07-24 1980-04-08 Unilever Nv Composicao cosmeticamente aceitavel para aplicacao topica,processo para preparar uma composicao,aplicador e processopara prover vantagem a pele
FR2524801B1 (fr) * 1982-04-09 1985-08-30 Goupil Jean Jacques Medicaments contenant un derive du psoralene
US4642318A (en) * 1982-11-17 1987-02-10 Klaus Wolff Method for decreasing radiation load in PUVA therapy
LU84979A1 (fr) * 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
LU85438A1 (fr) * 1984-06-27 1986-01-24 Oreal Association medicamenteuse utilisee en photochimiotherapie
FR2570602B1 (fr) * 1984-09-21 1986-11-28 Cird Vehicule pharmaceutique pour substances actives se presentant sous forme d'un gel anhydre
US4696946A (en) * 1985-08-30 1987-09-29 Schering Corporation Topical Treatment of hyperproliferative skin diseases
DE3531597A1 (de) * 1985-09-04 1987-03-05 Bioferon Biochem Substanz Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur behandlung psoriatischer erkrankungen
JPS63159489A (ja) * 1986-12-23 1988-07-02 Shin Etsu Chem Co Ltd ゲル状組成物
BE1000724A6 (fr) * 1987-05-20 1989-03-21 Stiefel Lab Ltd Compositions a base de dithranol.
US4868169A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steroid cream formulation
US5130135A (en) * 1989-08-18 1992-07-14 Smithkline Beecham Plc Pesticidal formulations

Also Published As

Publication number Publication date
AU671584B2 (en) 1996-09-05
WO1992017208A1 (en) 1992-10-15
GB9106365D0 (en) 1991-05-15
IE920975A1 (en) 1992-10-07
EP0702568B1 (de) 2001-01-03
JPH06507391A (ja) 1994-08-25
CA2106065A1 (en) 1992-09-27
DE69231628D1 (de) 2001-02-08
US5501849A (en) 1996-03-26
SG49928A1 (en) 1998-06-15
KR100243758B1 (ko) 2000-03-02
EP0702568A1 (de) 1996-03-27
NZ242148A (en) 1993-07-27
AU1432992A (en) 1992-11-02

Similar Documents

Publication Publication Date Title
FI973492A0 (fi) NO-syntaasin estäjät
DK0532862T3 (da) Anvendelse af rapamycin til fremstilling af et lægemiddel til behandling af øjeninflammation
DK0880350T3 (da) Behandling af dissemineret sklerose
ES2059965T3 (es) Un procedimiento para preparar una composicion farmaceutica para el tratamiento de enfermedades inflamatorias.
DE69532160D1 (de) Verfahren zur phototherapeutischen behandlung von proliferativen hauterkrankungen
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
FR2756739B1 (fr) Nouvelle formulation de budesonide
DK0751769T3 (da) Medicinsk behandling under anvendelse af skjoldbruskhormoner
DE69634776D1 (de) Verwendung eines r-nsaid als chemoschützendes mittel zur behandlung kolorektales krebs
ATE202923T1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
DE69535095D1 (de) Vorrichtung zum austeilen von gebrauchsfertiger visköser lösung sowie deren verwendung zum austeilen
DE69429427D1 (de) Behandlung von tumoren mit verbindungen mit einer rxr-retinoid agonistische wirkung
DK0918504T3 (da) Anvendelse af genistein som et forebyggende middel mod af ultraviolet stråling induceret hudfotobeskadigelse og cancer.
ES2156839T1 (es) Medicamento que contiene alginato e implante para tratar la fibrosis.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
BR9509006A (pt) Composiçao para aplicaçao tópica na pele composiçao farmacêutica uso de um inibidor de síntese de colesterol e processo para o tratamento mitigaçao ou prevençao de distúrbios de pele
DE69418601D1 (de) Guanidinderivate mit therapeutischer wirkung
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
DE69231628D1 (de) Erweichende zusammensetzung
DK71387A (da) Terapeutisk middel til behandling af psoriasis
DK0871438T3 (da) Anvendelse af alfa-hydroxysyrer ved fremstillingen af et medikament til behandling af inflammation
MX9400040A (es) Composiciones para tratar trastornos respiratorios.
MX9306005A (es) Combinaciones de ibupropeno-cafeina.
MX9304878A (es) Uso de un azaspirano substituido en la fabricacion de un medicamento para utilizarse en el tratamiento de psoriasis.
ES2101311T3 (es) Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties